Cargando…
A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans–A cohort study
Founder variants in sarcomere protein genes account for a significant proportion of disease-causing variants in patients with hypertrophic cardiomyopathy (HCM). However, information on founder variants in non-sarcomeric protein genes, such as FHOD3, which have only recently been associated with HCM,...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697513/ http://dx.doi.org/10.1371/journal.pone.0294969 |
_version_ | 1785154764537856000 |
---|---|
author | Vodnjov, Nina Toplišek, Janez Maver, Aleš Čuturilo, Goran Jaklič, Helena Teran, Nataša Višnjar, Tanja Škrjanec Pušenjak, Maruša Hodžić, Alenka Miljanović, Olivera Peterlin, Borut Writzl, Karin |
author_facet | Vodnjov, Nina Toplišek, Janez Maver, Aleš Čuturilo, Goran Jaklič, Helena Teran, Nataša Višnjar, Tanja Škrjanec Pušenjak, Maruša Hodžić, Alenka Miljanović, Olivera Peterlin, Borut Writzl, Karin |
author_sort | Vodnjov, Nina |
collection | PubMed |
description | Founder variants in sarcomere protein genes account for a significant proportion of disease-causing variants in patients with hypertrophic cardiomyopathy (HCM). However, information on founder variants in non-sarcomeric protein genes, such as FHOD3, which have only recently been associated with HCM, remains scarce. In this study, we conducted a retrospective analysis of exome sequencing data of 134 probands with HCM for recurrent pathogenic variants. We discovered a novel likely pathogenic variant c.1646+2T>C in FHOD3 in heterozygous state in eight probands with HCM and confirmed its presence in seven additional relatives. Individuals with this variant had a wide range of ages at onset of the disease (4–63 years). No adverse cardiac events were observed. Haplotype analysis revealed that the individuals with this variant shared a genomic region of approximately 5 Mbp surrounding the variant, confirming the founder effect of the variant. FHOD3 c.1646+2T>C is estimated to have arisen 58 generations ago (95% CI: 45–81) in a common ancestor living on the Balkans. A founder FHOD3 c.1646+2T>C variant is the second most common genetic variant in our cohort of patients with HCM, occurring in 16% of probands with a known genetic cause of HCM, which represents a substantially higher proportion than the currently estimated 0.5–2% for causal FHOD3 variants. Our study broadens the understanding of the genetic causes of HCM and may improve the diagnosis of this condition, particularly in patients from the Balkans. |
format | Online Article Text |
id | pubmed-10697513 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-106975132023-12-06 A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans–A cohort study Vodnjov, Nina Toplišek, Janez Maver, Aleš Čuturilo, Goran Jaklič, Helena Teran, Nataša Višnjar, Tanja Škrjanec Pušenjak, Maruša Hodžić, Alenka Miljanović, Olivera Peterlin, Borut Writzl, Karin PLoS One Research Article Founder variants in sarcomere protein genes account for a significant proportion of disease-causing variants in patients with hypertrophic cardiomyopathy (HCM). However, information on founder variants in non-sarcomeric protein genes, such as FHOD3, which have only recently been associated with HCM, remains scarce. In this study, we conducted a retrospective analysis of exome sequencing data of 134 probands with HCM for recurrent pathogenic variants. We discovered a novel likely pathogenic variant c.1646+2T>C in FHOD3 in heterozygous state in eight probands with HCM and confirmed its presence in seven additional relatives. Individuals with this variant had a wide range of ages at onset of the disease (4–63 years). No adverse cardiac events were observed. Haplotype analysis revealed that the individuals with this variant shared a genomic region of approximately 5 Mbp surrounding the variant, confirming the founder effect of the variant. FHOD3 c.1646+2T>C is estimated to have arisen 58 generations ago (95% CI: 45–81) in a common ancestor living on the Balkans. A founder FHOD3 c.1646+2T>C variant is the second most common genetic variant in our cohort of patients with HCM, occurring in 16% of probands with a known genetic cause of HCM, which represents a substantially higher proportion than the currently estimated 0.5–2% for causal FHOD3 variants. Our study broadens the understanding of the genetic causes of HCM and may improve the diagnosis of this condition, particularly in patients from the Balkans. Public Library of Science 2023-12-05 /pmc/articles/PMC10697513/ http://dx.doi.org/10.1371/journal.pone.0294969 Text en © 2023 Vodnjov et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Vodnjov, Nina Toplišek, Janez Maver, Aleš Čuturilo, Goran Jaklič, Helena Teran, Nataša Višnjar, Tanja Škrjanec Pušenjak, Maruša Hodžić, Alenka Miljanović, Olivera Peterlin, Borut Writzl, Karin A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans–A cohort study |
title | A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans–A cohort study |
title_full | A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans–A cohort study |
title_fullStr | A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans–A cohort study |
title_full_unstemmed | A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans–A cohort study |
title_short | A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans–A cohort study |
title_sort | novel splice-site fhod3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the balkans–a cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697513/ http://dx.doi.org/10.1371/journal.pone.0294969 |
work_keys_str_mv | AT vodnjovnina anovelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT toplisekjanez anovelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT maverales anovelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT cuturilogoran anovelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT jaklichelena anovelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT terannatasa anovelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT visnjartanja anovelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT skrjanecpusenjakmarusa anovelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT hodzicalenka anovelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT miljanovicolivera anovelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT peterlinborut anovelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT writzlkarin anovelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT vodnjovnina novelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT toplisekjanez novelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT maverales novelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT cuturilogoran novelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT jaklichelena novelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT terannatasa novelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT visnjartanja novelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT skrjanecpusenjakmarusa novelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT hodzicalenka novelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT miljanovicolivera novelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT peterlinborut novelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy AT writzlkarin novelsplicesitefhod3foundervariantisacommoncauseofhypertrophiccardiomyopathyinthepopulationofthebalkansacohortstudy |